46 Epizód

  1. Uncertainty reigns, but opportunity persists for biotech’s 2025

    Közzétéve: 2025. 02. 07.

  2. Unlocking Biotech’s Potential: Strategies for Navigating Public and Private Market Investments

    Közzétéve: 2024. 11. 22.

  3. Former Investor Who Chose Broadcasting Over Biotech ETFs

    Közzétéve: 2024. 09. 30.

  4. Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?

    Közzétéve: 2024. 08. 29.

  5. Shots-on-Goal Licensing Company Aims for Breakthroughs

    Közzétéve: 2024. 07. 19.

  6. Why Biopharma Needs to Tell Better Stories on Novel Drugs

    Közzétéve: 2024. 07. 11.

  7. Venture capital velocity: What’s driving renewed momentum in biotech?

    Közzétéve: 2024. 07. 08.

  8. Pharma Understands Phase One Data – But Does the Market?

    Közzétéve: 2024. 06. 21.

  9. Davern Capital sees GLP-1 Opportunities Beyond Obesity

    Közzétéve: 2024. 06. 14.

  10. Betting on Healthcare’s Future Hits – and Misses

    Közzétéve: 2024. 06. 10.

  11. Innovation and an Aging Population Drive MedTech

    Közzétéve: 2024. 06. 05.

  12. Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing

    Közzétéve: 2024. 06. 03.

  13. Biotech with a Mission to Target Unmet Cancer Needs

    Közzétéve: 2024. 05. 31.

  14. The M&A Pool Set to Accelerate Biotech Innovation

    Közzétéve: 2024. 04. 03.

  15. How PIPEs finally unblocked biotech’s funding flows

    Közzétéve: 2024. 03. 29.

  16. Disruptive Forces in Healthcare: Why HCIT is finally set to bounce back

    Közzétéve: 2024. 03. 07.

  17. Will the Biotech Rebound Run into Pricing Policy Obstacles?

    Közzétéve: 2024. 02. 27.

  18. Few IPOs but plenty of follow-on for biotech in 2023

    Közzétéve: 2024. 01. 22.

  19. U.S. Outlook: Will the US economy achieve a soft landing in 2024?

    Közzétéve: 2023. 12. 29.

  20. Raising Venture Capital: A New Playbook for A New Era in Biotech

    Közzétéve: 2023. 11. 22.

1 / 3

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

Visit the podcast's native language site